Randy Ban - 23 Feb 2024 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Commercial Officer
Signature
/s/ Bryan Phillips, Attorney-in-Fact for Randy Ban
Issuer symbol
INSP
Transactions as of
23 Feb 2024
Net transactions value
-$2,644,813
Form type
4
Filing time
27 Feb 2024, 20:39:52 UTC
Previous filing
13 Feb 2024
Next filing
19 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Options Exercise $10,613 +11,290 +373% $0.9400* 14,319 23 Feb 2024 Direct
transaction INSP Common Stock Options Exercise $39,621 +940 +6.6% $42.15 15,259 23 Feb 2024 Direct
transaction INSP Common Stock Sale $2,267,075 -12,230 -80% $185.37 3,029 23 Feb 2024 Direct F1
transaction INSP Common Stock Options Exercise $128,979 +3,060 +101% $42.15 6,089 27 Feb 2024 Direct
transaction INSP Common Stock Sale $556,951 -3,060 -50% $182.01 3,029 27 Feb 2024 Direct F2
holding INSP Common Stock 167 23 Feb 2024 By son
holding INSP Common Stock 166 23 Feb 2024 By daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -11,090 -100% $0.000000* 0 23 Feb 2024 Common Stock 11,090 $0.9400 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -200 -100% $0.000000* 0 23 Feb 2024 Common Stock 200 $0.9400 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -940 -3.8% $0.000000 24,060 23 Feb 2024 Common Stock 940 $42.15 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -3,060 -13% $0.000000 21,000 27 Feb 2024 Common Stock 3,060 $42.15 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.00 to $186.44. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.00 to $182.25. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The option is fully vested and exercisable.